This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Samuel Packer, MD

Arch Ophthalmol. 1997;115(5):666-667.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE INTRODUCTION of the excimer laser for photorefractive keratotomy (PRK) has brought with it not only a new technology but a new partner in medical care. New corporations have been established to help introduce this new technology. This is no doubt in part due to the high cost but also may be due to the fact that the marketing required to achieve economic viability is something that medical professionals are either uncomfortable with or would rather that someone else do.¹

Thus, new contractual relationships between ophthalmologists and laser companies are being formed. This may allow for more citizens to be informed of this new technology and for it to be made more readily available to them. However, this new technology and this new partnership have the potential to create notable ethical problems, in areas such as (1) agency, (2) conflicts of interest, (3) informed consent, (4) marketing and advertising, . . . [Full Text PDF of this Article]

Author Affiliations
Great Neck, NY

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?